Anaptysbio Inc (ANAB)

EBITDA Margin

38.68%

TTM · Period ending:

ANAB logo

ANAB EBITDA Margin

Latest reported38.68%
ANAB TTM EBITDA Margin (32.52% → 38.68%)
High-resolution chart · PNG

ANAB ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Anaptysbio Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
38.6793%
25.1695%
29.5171%
-2.6967%
-48.4314%
-68.2646%
-101.6269%
-215.4044%
-454.8092%
-602.6958%
-820.0909%
-855.9024%
-947.3521%
-1,064.0258%
-1,023.204%
-2,580.8024%
-394.7897%
-129.7251%
-88.3767%
8.2766%
-7.2319%
-40.295%
-25.0573%
-402.9333%
-443.3611%
-358.6652%
-1,200.4125%
-1,856.06%
-775.61%
-1,339.24%
-1,197.62%
-619.05%
-1,421.6333%
-317.25%
-281.12%
-268.2284%
-142.7514%
-116.9403%
-21.3858%
-13.3841%
-10.8297%
-24.3021%
-22.3607%
-0.5458%
21.5893%
29.8281%
32.5167%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.